158 related articles for article (PubMed ID: 6388524)
1. Treatment of bulimia with phenelzine. A double-blind, placebo-controlled study.
Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
Arch Gen Psychiatry; 1984 Nov; 41(11):1105-9. PubMed ID: 6388524
[TBL] [Abstract][Full Text] [Related]
2. A double-blind trial of phenelzine in bulimia.
Walsh BT; Stewart JW; Roose SP; Gladis M; Glassman AH
J Psychiatr Res; 1985; 19(2-3):485-9. PubMed ID: 3900362
[TBL] [Abstract][Full Text] [Related]
3. Phenelzine vs placebo in 50 patients with bulimia.
Walsh BT; Gladis M; Roose SP; Stewart JW; Stetner F; Glassman AH
Arch Gen Psychiatry; 1988 May; 45(5):471-5. PubMed ID: 3282482
[TBL] [Abstract][Full Text] [Related]
4. Double-blind, placebo-controlled studies of bulimic patients.
Rosebush P
Am J Psychiatry; 1986 Sep; 143(9):1197-8. PubMed ID: 3529997
[No Abstract] [Full Text] [Related]
5. Treating bulimia with desipramine. A double-blind, placebo-controlled study.
Hughes PL; Wells LA; Cunningham CJ; Ilstrup DM
Arch Gen Psychiatry; 1986 Feb; 43(2):182-6. PubMed ID: 3511878
[TBL] [Abstract][Full Text] [Related]
6. Bulimia treated with imipramine: a placebo-controlled, double-blind study.
Pope HG; Hudson JI; Jonas JM; Yurgelun-Todd D
Am J Psychiatry; 1983 May; 140(5):554-8. PubMed ID: 6342421
[TBL] [Abstract][Full Text] [Related]
7. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
[TBL] [Abstract][Full Text] [Related]
8. An open trial of MAO inhibitors in bulimia.
Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
[TBL] [Abstract][Full Text] [Related]
9. Phenelzine for chronic depression: a study of continuation treatment.
Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
[TBL] [Abstract][Full Text] [Related]
10. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
Stewart JW; Harrison W; Cooper TB; Quitkin FM
Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
[TBL] [Abstract][Full Text] [Related]
11. A double-blind placebo-controlled comparison of phenelzine and imipramine in the treatment of bulimia in atypical depressives.
Rothschild R; Quitkin HM; Quitkin FM; Stewart JW; Ocepek-Welikson K; McGrath PJ; Tricamo E
Int J Eat Disord; 1994 Jan; 15(1):1-9. PubMed ID: 8124322
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant specificity in atypical depression.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison WM; Markowitz JS; Rabkin JG; Tricamo E; Goetz DM; Klein DF
Arch Gen Psychiatry; 1988 Feb; 45(2):129-37. PubMed ID: 3276282
[TBL] [Abstract][Full Text] [Related]
13. Bulimia nervosa: a placebo controlled double-blind therapeutic trial of mianserin.
Sabine EJ; Yonace A; Farrington AJ; Barratt KH; Wakeling A
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):195S-202S. PubMed ID: 6337607
[No Abstract] [Full Text] [Related]
14. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders.
Quitkin FM; Stewart JW; McGrath PJ; Liebowitz MR; Harrison WM; Tricamo E; Klein DF; Rabkin JG; Markowitz JS; Wager SG
Am J Psychiatry; 1988 Mar; 145(3):306-11. PubMed ID: 3278631
[TBL] [Abstract][Full Text] [Related]
15. Phenelzine v imipramine in atypical depression. A preliminary report.
Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
[TBL] [Abstract][Full Text] [Related]
16. Defining the boundaries of atypical depression.
Quitkin FM; Harrison W; Liebowitz M; McGrath P; Rabkin JG; Stewart J; Markowitz J
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):19-21. PubMed ID: 6376482
[TBL] [Abstract][Full Text] [Related]
17. l-Deprenyl in atypical depressives.
Quitkin FM; Liebowitz MR; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Markowitz J; Davies SO
Arch Gen Psychiatry; 1984 Aug; 41(8):777-81. PubMed ID: 6430257
[TBL] [Abstract][Full Text] [Related]
18. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
Paykel ES; Rowan PR; Parker RR; Bhat AV
Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
[TBL] [Abstract][Full Text] [Related]
19. Monoamine oxidase inhibitor therapy for anorexia nervosa and bulimia: a preliminary trial of isocarboxazid.
Kennedy SH; Piran N; Garfinkel PE
J Clin Psychopharmacol; 1985 Oct; 5(5):279-85. PubMed ID: 3862680
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients.
Georgotas A; McCue RE; Cooper TB
Arch Gen Psychiatry; 1989 Sep; 46(9):783-6. PubMed ID: 2673129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
